Overview

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

Status:
Completed
Trial end date:
2018-05-20
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of PRX-100 compared with aceclidine alone and vehicle in the treatment of early to moderate presbyopia.
Phase:
Phase 2
Details
Lead Sponsor:
Presbyopia Therapies, LLC
Treatments:
Aceclidine
Ophthalmic Solutions
Pharmaceutical Solutions
Tropicamide